Polygon Management »

Celcuity shares owned by Polygon Management

Quarter-by-quarter ownership of Celcuity (CELC) shares owned by Polygon Management from 13F filings

Historical chart of Polygon Management investment in Celcuity

Tip: Access up to 7 years of quarterly data

All positions including Celcuity held by Polygon Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celcuity by Polygon Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $6.7M 64k 104.62

More positions owned by Polygon Management

Uipath Cl A (PATH)
Kolibri Global Energy Com New (KGEI)
Autolus Therapeutics Spon Ads (AUTL)
Lyft Cl A Com (LYFT)
Definium Therapeutics Com Shs (DFTX)
Workiva Com Cl A (WK)
Silence Therapeutics Ads Call Option (SLN)
Sprinklr Cl A (CXM)
Mbx Biosciences (MBX)
Alkami Technology (ALKT)
Celldex Therapeutics Com New (CLDX)
Relay Therapeutics (RLAY)
Arrowhead Pharmaceuticals (ARWR)
Pharvaris N V (PHVS)
Alkermes SHS (ALKS)

View all positions for Polygon Management

Top funds holding Celcuity

Baker Bros. Advisors
venBio Select Advisor
Rtw Investments
Perceptive Advisors
BlackRock
Vanguard Capital Management
NEA Management Company
Soleus Capital Management
State Street Corporation
Bank of America Corporation
Deerfield Management Company
Morgan Stanley
Tang Capital Management
T. Rowe Price Associates
Toronto-Dominion Bank

View all funds holding Celcuity